Skip to content

MAGNETICAL - MAGNetic resonance Evaluation of Tafamidis Impact in Cardiac AmyLoidosis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518708-29-00
Acronym
MGNT2022
Enrollment
30
Registered
2024-11-06
Start date
2024-03-13
Completion date
Unknown
Last updated
2024-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transthyretin cardiac amyloidosis

Brief summary

Change from baseline at each point in CMR imaging parameters, including: ventricular volumes, mass, ejection fraction; native T1 and T2 mapping; ECV; LookLocker at 2, 5 and 10 minutes; LGE, Strain analysis and 4D flow

Detailed description

Frequency of heart failure related hospitalization and all-cause mortality, Change from baseline at each point in the Kansas City Cardiomyopathy, Questionnaire overall score, Change from baseline at each point in 6MWT distance, Change from baseline at each point in NT-proBNP concentration, Change from baseline at each point in NYHA classification, Change from baseline at each point in echocardiographic parameters

Interventions

Sponsors

Unidade Local De Saude De Tras-Os-Montes E Alto Douro E.P.E.
Lead SponsorOTHER

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Change from baseline at each point in CMR imaging parameters, including: ventricular volumes, mass, ejection fraction; native T1 and T2 mapping; ECV; LookLocker at 2, 5 and 10 minutes; LGE, Strain analysis and 4D flow

Secondary

MeasureTime frame
Frequency of heart failure related hospitalization and all-cause mortality, Change from baseline at each point in the Kansas City Cardiomyopathy, Questionnaire overall score, Change from baseline at each point in 6MWT distance, Change from baseline at each point in NT-proBNP concentration, Change from baseline at each point in NYHA classification, Change from baseline at each point in echocardiographic parameters

Countries

Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026